Searchable abstracts of presentations at key conferences in endocrinology

ea0041gp51 | Cardiovascular endocrinology | ECE2016

Pericardial rather than intramyocardial fat is independently associated with systolic and diastolic left ventricular heart function in metabolically healthy humans

Wolf Peter , Winhofer Yvonne , Smajis Sabina , Jankovic Drazenka , Anderwald Christian-Heinz , Trattnig Siegfried , Luger Anton , Krebs Michael , Krssak Martin

Background: Obesity is a major risk factor to develop heart failure, in part due to possible lipotoxic effects of increased intramyocardial (MYCL) and/or pericardial (PERI) lipid accumulation. Recent evidence suggests that MYCL is highly dynamic and might rather be a surrogate marker for disturbed energy metabolism than the underlying cause of cardiac dysfunction. On the other hand, PERI might contribute directly by mechanic and paracrine effects. Therefore, we hypothesized th...

ea0035p129 | Calcium and Vitamin D metabolism | ECE2014

Cardio-metabolic phenotyping of patients with familiar hypocalciuric hypercalcemia

Wolf Peter , Krssak Martin , Winhofer Yvonne , Anderwald Christian , Zwettler Elisabeth , Trattnig Siegfried , Luger Anton , Baumgartner-Parzer Sabina , Krebs Michael

Introduction: Heterozygous inactivating mutations of the calcium sensing receptor (CaSR) gene cause mild alterations in calcium metabolism (familiar hypocalciuric hypercalcemia (FHH)). However, in addition to the parathyroid gland CaSR expression was recently identified in the myocardium and many other endocrine cells including pancreatic islet cells, entero-endocine cells and adipose tissue. So far, it is unknown whether FHH is associated with cardio-metabolic altera...

ea0063gp189 | Adrenal and Neuroendocrine - Clinical | ECE2019

Plasma renin concentration is associated with cardiac function and morphology in primary adrenal insufficiency

Wolf Peter , Beiglbock Hannes , Fellinger Paul , Pfleger Lorenz , Aschauer Stefan , Gessl Alois , Trattnig Siegfried , Kautzky-Willer Alexandra , Luger Anton , Winhofer Yvonne , Krssak Martin , Krebs Michael

Background: Despite adequate glucocorticoid (GC) and mineralocorticoid (MC) replacement therapy, primary adrenal insufficiency (AI) is associated with an increased mortality, mainly due to cardiovascular disease. The role of MC replacement is not known. Therefore we assessed whether renin concentrations during routine GC and MC substitution therapy are associated with cardiac function and morphology.Methods: 17 patients with AI underwent magnetic resonan...

ea0049ep638 | Growth hormone IGF axis - basic | ECE2017

GH is related to hepatic mitochondrial activity in humans

Wolf Peter , Smajis Sabina , Gajdosiik Martin , Pfleger Lorenz , Winhofer Yvonne , Anderwald Christian-Heinz , Trattnig Siegfried , Luger Anton , Krssak Martin , Krebs Michael

Background: Altered hepatic mitochondrial activity plays a key role in the development of non-alcoholic fatty liver disease (NAFLD). GH has been shown to stimulate mitochondrial function in skeletal muscle. Therefore we hypothesize that the time course of serum GH concentrations during an oral glucose tolerance test might be related to hepatic mitochondrial energy metabolism in vivo in humans.Methods: 15 volunteers (male/female: 7/8; 55±8 y...

ea0041gp122 | Neuroendocrinology | ECE2016

Lipid content and ATP metabolism in the liver of patients with acromegaly

Winhofer Yvonne , Wolf Peter , Smajis Sabina , Krssak Martin , Gajdosik Martin , Micko Alexander , Wolfsberger Stefan , Knosp Engelbert , Vila Greisa , Raber Wolfgang , Trattnig Siegfried , Luger Anton , Krebs Michael

We have recently shown that patients with growth hormone (GH) excess (acromegaly) exhibit inadequately low intrahepatic lipid content (IHL) despite marked insulin resistance. GH might increase mitochondrial oxidation capacity thereby counteracting ectopic lipid accumulation; however, up-regulation of mitochondrial function has been reported in early stages of non-alcoholic fatty liver disease. Up to now, data on mitochondrial activity in patients with acromegaly are missing.</...

ea0037gp.16.01 | Diabetes and obesity–Clinical obesity and cardiovascular | ECE2015

Suppression of plasma free fatty acid concentrations similarly reduces myocardial lipid content and left ventricular systolic function in type 2 diabetic patients and healthy controls

Wolf Peter , Winhofer Yvonne , Smajis Sabina , Catic Anja , Harreiter Jurgen , Kosi-Trebotic Lana , Trattnig Siegfried , Baumgartner-Parzer Sabina , Luger Anton , Krssak Martin , Krebs Michael

Background: Metabolic inflexibility in T2DM might result in reliance on free fatty acids (FFA) as substrates to maintain myocardial energy metabolism compared to lean and healthy controls. Thus, we investigated the effects of an acute suppression of circulating FFA on myocardial lipid content and left ventricular function in extreme phenotypes.Methods: T2DM patients (age: 56±11a; BMI: 28±3.5 kg/m2; HbA1c: 7.29±0.88%) and nine he...

ea0073aep62 | Adrenal and Cardiovascular Endocrinology | ECE2021

Patients with congenital adrenal hyperplasia show an adverse cardiovascular risk profile compared to patients with autoimmune adrenalitis

Hannes Beiglböck , Magdalena Bögl , Fellinger Paul , Metz Matthaeus , Vila Greisa , Luger Anton , Trattnig Siegfried , Kautzky-Willer Alexandra , Krssak Martin , Krebs Michael , Peter Wolf

BackgroundDespite adequate hormone replacement therapy, evidence suggests an increased mortality in patients suffering from primary adrenal insufficiency, mainly because of cardiovascular diseases. Congenital adrenal hyperplasia (CAH) and autoimmune adrenalitis (AI) are two entities with a different pathophysiological background and might therefore show divergent cardiovascular risk profiles.Methods9 patients...